Navigation Links
Addus HomeCare Reports Third Quarter 2010 Results
Date:11/4/2010

k-based compensation expense. Adjusted EBITDA is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP. (2) Medicare admissions represents the aggregate number of new cases approved for Medicare services during a specified period. Adjusted EBITDA (1) (Unaudited)

For the Three Months
Ended September 30,For the Nine Months
Ended September 30,2010200920102009Reconciliation of Adjusted EBITDA to Net Income:Net income

$ 1,479$ 2,090$   4,491$   5,386Net interest expense

8551,0212,3233,189Income tax expense

4639351,9472,409Depreciation and amortization

1,0581,2342,9553,678Stock-based compensation expense

6970197212Adjusted EBITDA

$ 3,924$ 5,350$ 11,913$ 14,874(1) We define Adjusted EBITDA as earnings before interest, taxes, depreciation, amortization, and stock-based compensation expense. Adjusted EBITDA is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.
'/>"/>

SOURCE Addus HomeCare Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. American Association for Homecare Backs Bipartisan Bill to Eliminate Medicare Bidding Program for Home Medical Equipment
2. American Association for Homecare Proposes Strong Anti-Fraud Measures in Medicare, Applauds HHS Testimony Today That Pledges to "Stop Fraud Before it Starts"
3. Home Medical Equipment Providers and Lawmakers Discuss Cost-Effective Role of Homecare During Washington Meeting
4. NewLife Homecare Partners With ChronoMed to Offer Customized Nutritional Program for Bleeding Disorder Community
5. New Jersey Home Medical Providers Call on Congress to Preserve Homecare as an Option for Seniors and People with Disabilities
6. New York Home Medical Providers Call on Congress to Preserve Homecare as an Option for Seniors and People With Disabilities
7. California Home Medical Providers Call on Congress to Preserve Homecare as an Option for Seniors and People with Disabilities Under Medicare
8. Michigan Home Medical Providers Call on Congress to Preserve Homecare as an Option for Seniors and People With Disabilities Under Medicare
9. Homecare Provider Testifies on Downside of Medicare Competitive Bidding Program Before House Energy and Commerce Subcommittee
10. Delta Health Technologies ClinicalVirtuoso™ Targets Homecare Therapists
11. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... 2015 Rock Creek Pharmaceuticals, Inc., (NASDAQ: ... inflammatory disease and neurologic disorders, announced today the results ... citrate, the Company,s lead compound. Results from the study ... can significantly inhibit the activation of inflammatory proteins in ... this compound in a Phase 1 clinical trial under ...
(Date:7/1/2015)... , July 1, 2015  BioPharmX Corporation (NYSE MKT: ... underwritten public offering of 3,636,364 shares of its common ... per share. BioPharmX has granted the underwriters a 30-day ... common stock at the public offering price. ... an existing stockholder, has agreed to purchase 1,081,081 shares ...
(Date:6/30/2015)... Scotland , July 1, 2015 ... joins Nu C ana team   ... ProTide technology to develop and commercialise a portfolio of ... Chris McGuigan as Chief Scientific Officer. ... ProTide technology. He is currently Professor of Medicinal Chemistry ...
Breaking Medicine Technology:Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 2Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 3Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 4BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 2BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 3Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 2Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 3
... Amgen (Nasdaq: AMGN ), today announced the ... privately held biotechnology company based in Woburn, Mass., with ... a novel investigational oncolytic vaccine in Phase 3 clinical ... melanoma and head and neck cancer. The acquisition was ...
... , a leader in bioinformatics software and knowledge integration, ... license for Pathway Studio ® Enterprise system that ... MedScan® text processing technology for site-wide use. Pathway Studio ... pathways and develop mechanistic rationale for disease based on ...
Cached Medicine Technology:Amgen Completes Acquisition of BioVex 2Amgen Completes Acquisition of BioVex 3Amgen Completes Acquisition of BioVex 4Site-wide License for Ariadne's Pathway Studio Renewed by NCI 2
(Date:7/1/2015)... Tenn. (PRWEB) , ... July 01, 2015 , ... The ... held rain or shine Saturday, July 11, 2015, at 6 p.m. in Pugh Bourne ... free and includes pony rides, a petting zoo, an Elvis impersonator, a silent auction ...
(Date:7/1/2015)... Miami, Florida (PRWEB) , ... July 01, 2015 ... ... effects for society,” said lead author Lisa Stolzenberg, a Professor in FIU’s School ... on juveniles aged 12 to 17 years who participated in the National Survey ...
(Date:7/1/2015)... ... July 01, 2015 , ... Element Blue ™, ... today that it has received trademark protection for its SensorInsight® computer software platform. ... data from multiple sources providing an environment where users can view and compare ...
(Date:7/1/2015)... San Luis Obispo, CA (PRWEB) , ... July ... ... in non-surgical bunion treatment, announces their big summer sale. Customers purchasing two ... $15 with promo code "Summer15". , Bunion Bootie temporarily corrects misaligned ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... healthcare providers, has been retained to lead a national chief executive officer ... executive search firms in the healthcare industry, B. E. Smith has recently placed ...
Breaking Medicine News(10 mins):Health News:Researchers find that medical marijuana laws increase recreational marijuana use among juveniles 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 3Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 4Health News:Bunion Bootie, the #1 Non-Surgical Treatment for Bunion Pain, Announces Their Big Summer Sale 2Health News:Citizens Medical Center Retains B. E. Smith to Recruit New CEO 2Health News:Citizens Medical Center Retains B. E. Smith to Recruit New CEO 3
... the birth,of a daughter to 17-year-old actress Jamie Lynn ... issued the following,statement from CEO Sarah Brown:, "Every ... Jamie Lynn,Spears, new daughter, Maddie Briann, will be surrounded ... that is sure to now erupt, as it,did when ...
... Federal Reserve chairman Ben Bernanke,s,comments this week that ... one of the biggest challenges facing the nation, plus ... rise nearly 10 percent this,year, lend strong support to ... wellness, according to U.S. Preventive Medicine, the leader,in disease ...
... Cohera Medical Inc. today announced,that data published in ... the company,s surgical adhesive, TissuGlu, was effective in ... model., Summarized in a paper titled "Lysine-Derived ... Abdominoplasty Model," (Plast.,Reconstr. Surg. 2008; Vol. 122, Issue ...
... working to develop inexpensive paper that can destroy, deactivate ... will share their expertise with the world as the ... next week in Espoo, Finland. More than 80 science, ... will meet in the city northwest of Helsinki for ...
... proposes $2.29 billion hospice rate,cut, WASHINGTON, ... providers representing all 50 states are calling ... the Administration from slashing,the hospice reimbursement under ... millions of Americans nearing the end of,their ...
... The plant, Kalanchoe fedtschenkoi, is unique because, unlike normal plants, ... the air is cooler and more humid, making it 10 ... Scientists will use the latest next-generation DNA sequencing to analyse ... at night. , The project will generate a genome ...
Cached Medicine News:Health News:National Campaign to Prevent Teen and Unplanned Pregnancy Statement on Jamie Lynn Spears 2Health News:U.S. Preventive Medicine Views Bernanke's Comments as Strong Support for Prevention and Wellness Programs 2Health News:Data Published in Plastic and Reconstructive Surgery Show Cohera Medical's Surgical Adhesive, TissuGlu(R), Prevents Seroma Formation in Animal Abdominoplasty Model 2Health News:Data Published in Plastic and Reconstructive Surgery Show Cohera Medical's Surgical Adhesive, TissuGlu(R), Prevents Seroma Formation in Animal Abdominoplasty Model 3Health News:World research leaders gather in Finland to accelerate the development of bioactive paper 2Health News:Hospice Programs Nationwide Urge Congress to Act on Behalf of End-of Life Patients 2
... OmniMD Medical Billing system allows a ... accounting. It is integrated with the ... The system interfaces with electronic clearinghouses ... With a set of reports, it ...
... CPNG3 single liquid stable reagent offers ... single liquid stability to help maximize ... provide quick result turnaround time. The ... CPNG3 reagent provides a long shelf ...
... Infinity Uric Acid single liquid stable ... convenience of single liquid stability to ... error and provide quick result turnaround ... Infinity Uric Acid reagent provides a ...
... Oxidase single liquid stable reagent offers ... single liquid stability to help maximize ... provide quick result turnaround time. The ... Oxidase reagent provides a long shelf ...
Medicine Products: